Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Blanke

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Low dose versus high dose imatinib for gastrointestinal stromal tumorsCharles Blanke
Clinical Advances in Hematology & Oncology : H&O|August 9, 2007
Current management of GISTCharles Blanke
Clinical Advances in Hematology & Oncology : H&O|June 17, 2010
Current management of GISTsCharles Blanke
Clinical Advances in Hematology & Oncology : H&O|November 14, 2006
Current and future management of GISTCharles Blanke
Cancer Investigation|June 18, 2004
Role of COX-2 inhibitors in cancer therapyCharles Blanke
JAMA Oncology|February 17, 2018
Oregon's Death With Dignity Act-ReplyCharles Blanke, Lee Ellis, Frank Meyskens
The American Journal of Gastroenterology|September 27, 2005
Epidemiology of GISTCharles Blanke, Burton L Eisenberg, Michael Heinrich
Gastrointestinal Cancer Research : GCR|December 17, 2009
Accomplishments in 2008 in the management of gastrointestinal stromal tumorsDaniel Renouf, Jean-Yves Blay, Charles Blanke
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 30, 2008
Evaluation of the tumor board as a Continuing Medical Education (CME) activity: is it useful?Maryclare Sarff, Wendy Rogers, Charles Blanke, et al.
JAMA Oncology|April 7, 2017
Characterizing 18 Years of the Death With Dignity Act in OregonCharles Blanke, Michael LeBlanc, Dawn Hershman, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Low dose versus high dose imatinib for gastrointestinal stromal tumorsCharles Blanke
Clinical Advances in Hematology & Oncology : H&O|August 9, 2007
Current management of GISTCharles Blanke
Clinical Advances in Hematology & Oncology : H&O|June 17, 2010
Current management of GISTsCharles Blanke
Clinical Advances in Hematology & Oncology : H&O|November 14, 2006
Current and future management of GISTCharles Blanke
Cancer Investigation|June 18, 2004
Role of COX-2 inhibitors in cancer therapyCharles Blanke
JAMA Oncology|February 17, 2018
Oregon's Death With Dignity Act-ReplyCharles Blanke, Lee Ellis, Frank Meyskens
The American Journal of Gastroenterology|September 27, 2005
Epidemiology of GISTCharles Blanke, Burton L Eisenberg, Michael Heinrich
Gastrointestinal Cancer Research : GCR|December 17, 2009
Accomplishments in 2008 in the management of gastrointestinal stromal tumorsDaniel Renouf, Jean-Yves Blay, Charles Blanke
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 30, 2008
Evaluation of the tumor board as a Continuing Medical Education (CME) activity: is it useful?Maryclare Sarff, Wendy Rogers, Charles Blanke, et al.
JAMA Oncology|April 7, 2017
Characterizing 18 Years of the Death With Dignity Act in OregonCharles Blanke, Michael LeBlanc, Dawn Hershman, et al.
Pageof 4